跳至主要内容
临床试验/NCT07118813
NCT07118813招募中不适用

Application of Radiomics-based AI Models in Predicting Clinical Outcome of Patients With Renal Cell Carcinoma After Surgical Treatment (AI-Kidney-Prognosis)

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology1 个研究点 分布在 1 个国家目标入组 400 人开始时间: 2025年8月1日最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
400
试验地点
1
主要终点
Progression-free survival

研究概览

简要总结

This is a prospective observational cohort study (AI-Kidney-Prognosis), aiming to non-invasively predict the clinical outcomes in renal cell carcinoma patients after surgical treatment using radiomics-based AI models, thereby assisting clinical decision-making and personalized follow-up strategies.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients were treated for renal cell carcinoma in Wuhan Union Hospital from August 2025 to August 2026;
  • Aged > 18 years old;
  • At least one abdominal CT scan before treatment;
  • Tissue biopsy pathological examination confirmed the diagnosis of renal cell carcinoma.

排除标准

  • Poor image quality;
  • Incomplete clinical data or loss of follow-up;
  • Presence of another primary malignancy other than renal cell carcinoma;
  • Unclear pathological diagnosis.

结局指标

主要结局

Progression-free survival

时间窗: 1 year

次要结局

未报告次要终点

研究者

发起方
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验